TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04111432

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Concomitant administration of EV71vaccine with EPI vaccines
Description: The investigated EV17 vaccine was manufactured by Sinovac Biotech Co., Ltd.# the MMR vaccine was manufactured by Shanghai Institute of Biological Products Co.,Ltd.; the Live attenuated Japanese encephalitis vaccine was manufactured by Chengdu Institute of Biological Products Co.,Ltd.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Single injection of EPI vaccine
Description: The MMR vaccine was manufactured by Shanghai Institute of Biological Products Co.,Ltd.; the Live attenuated Japanese encephalitis vaccine was manufactured by Chengdu Institute of Biological Products Co.,Ltd.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: EV71 Vaccine only
Description: The investigated EV17 vaccine was manufactured by Sinovac Biotech Co., Ltd.
Study: NCT03912194

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: relaxation strategies
Description: Participants will generate and refine relaxation techniques with the aid of a therapist

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: relaxation strategies
Description: Participants will generate and refine relaxation techniques with the aid of a therapist

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: early withdrawal exposure
Description: Exposure to the first 4 hours of abstinence across 4 separate sessions

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: early withdrawal exposure
Description: Exposure to the first 4 hours of abstinence across 4 separate sessions
Study: NCT03250715

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy
Description: For application of the LLLT in the quadriceps muscle the patient will be in dorsal decubitus, with the legs extended and will be defined by the palpation of the muscle belts six points of application: two points in the distal region of the vastus medialis muscle, two points of the distal region of the vastus lateral muscle and two points of the central region of the rectus femoris muscle. For the application of LLLT in the gastrocnemius muscle the patient will remain in the supine position, but will be oriented to keep the hips and knees flexed at 90º and 45º respectively. Two application points will be defined, one in the lateral ventricle and the other in the medial ventricle, but both in the distal region of the muscle.
Study: NCT03254797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stepping training with feedback
Description: Subjects stand in a step standing position with placing one leg on the load cells of the device and the other leg at the posterolateral direction to the trained leg outside the load cells, look at the displayed section which will be positioned at their eye level. Then subjects will be instructed to shift/take their body-weight onto the trained leg until the green zone of the displayed section is lightened. When the subjects can take a proper level of their body-weight onto the trained leg, the beep sound will be alarmed to trigger the subjects and therapist that the subjects can step the other leg forward to the marker. Then they have to do the same when steps the leg backward.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stepping training without feedback
Description: Subjects stand in a step standing position with placing one leg on the load cells of the device and the other leg at the posterolateral direction to the trained leg outside the load cells. Then subjects will be instructed to shift/take their body-weight onto the trained leg as most as they can. If the subjects can take a proper level of their body-weight onto the trained leg, the subjects can step the other leg forward to the marker. Then they have to do the same when steps the leg backward.
Study: NCT02628873

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HyCoSy
Description: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HyCoSy
Description: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes
Study: NCT01619280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside
Description: Each subject will receive one of five possible dosages of nebulized sodium nitroprusside. The dosage will be determined by the 3 + 3 dose escalation design. Only a maximum of six patients will be given a particular dosage. Arterial blood gases will be drawn at 0 min, 15 min, 30 min and 45 min during nebulized sodium nitroprusside administration. Vitals signs will be recorded every five minutes. No changes to ventilator settings or vasopressor dosage or fluid administration will be allowed.
Study: NCT04680494

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: moderate intensity physical exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high intensity physical exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rest
Study: NCT02378454

Intervention type: DEVICE
Intervention: Comparison of two MBWN2 devices : EasyOne Pro Lab versus Exhalyzer D
Description: Healthy and Cystic Fibrosis participants will perform the same day MBWN2 tests in duplicate with each device.

Intervention type: DEVICE
Intervention: Comparison of two MBWN2 devices : EasyOne Pro Lab versus Exhalyzer D
Description: Healthy and Cystic Fibrosis participants will perform the same day MBWN2 tests in duplicate with each device.
Study: NCT00517777

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: continuous positive airway pressure ventilation
Description: nighttime

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: dietary and life style recommendations

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: dietary and life style recommendations
Study: NCT03839407

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MUSE Meditation Device
Description: The MUSE Meditation Device guides users in mindful meditation using real-time feedback on brain wave activity.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MUSE Meditation Device
Description: The MUSE Meditation Device guides users in mindful meditation using real-time feedback on brain wave activity.
Study: NCT01877863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: 12 weeks of intradialytic biking at Borg intensity 3 - 4 for 15 to 60 minutes on each dialysis run
Study: NCT01672788

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empagliflozin
Description: empagliflozin tablets and metformin tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin + Metformin
Description: fixed dose combination tablet (low)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: empagliflozin tablets and metformin tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: empagliflozin tablet and metformin tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin + Metformin
Description: fixed dose combination tablet (low)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empagliflozin
Description: empagliflozin tablet and metformin tablet
Study: NCT01509326

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: chiropractic treatment
Description: 12 sessions over 4 weeks

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dr. Zaxx pillow
Description: Daily use of an acupressure pillow
Study: NCT04271007

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate
Description: mometasone furoate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate
Description: mometasone furoate
Study: NCT01940354

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AccuCath IV Catheter System
Description: Vascular access and indwelling catheter placement via study device for infusion of fluids and removal of blood samples.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional IV Catheter System
Description: Vascular access and indwelling catheter placement via control device for infusion of fluids and removal of blood samples
Study: NCT01538953

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: handwashing
Description: participants received weekly in-home handwashing promotion and soap as needed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: handwashing
Description: participants received weekly in-home handwashing promotion and soap as needed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: flocculent-disinfectant for water treatment
Description: participants received a supply of flocculent-disinfectant product for water treatment and instruction in how to use it

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: flocculent-disinfectant for water treatment
Description: participants received a supply of flocculent-disinfectant product for water treatment and instruction in how to use it

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: water treatment with sodium hypochlorite
Description: participants received a supply of dilute sodium hypochlorite and instruction to treat drinking water with it
Study: NCT02367235

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Traditional vaginal positioning device
Description: A vaginally placed endo-anal sizer will be used to position the vagina during surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Colpassist vaginal positioning device
Description: A vaginally placed Colpassist will be used to position the vagina during surgery.
Study: NCT04820777

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: perturbation training
Description: external or internal postural perturbations. External perturbations occur by forces outside the patient' control (e.g., a push or pull from the physiotherapist). Internal perturbations caused when the patient is unable to control the centre of mass and the base of support relationship during voluntary movement; 'agility' tasks, such as kicking a soccer ball,

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional' balance training
Description: Starting from a situated position, expand your left leg until it's corresponding to the floor. Try not to bolt your knee. At that point, gradually bring your foot down to the floor. Rehash with your correct leg, exchanging to and fro between legs for a s
Study: NCT04578912

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Comprehensive Behavioral Intervention for Tics (CBIT)
Description: CBIT is a manualized treatment program focused on tic management skills

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Comprehensive Behavioral Intervention for Tics (CBIT)
Description: CBIT is a manualized treatment program focused on tic management skills

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Comprehensive Behavioral Intervention for Tics (CBIT)
Description: CBIT is a manualized treatment program focused on tic management skills

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: During repetitive transcranial magnetic stimulation (rTMS), a electromagnetic coil is placed against the scalp while an electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the target brain region

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Theta Burst Stimulation (cTBS)
Description: During continuous theta burst stimulation (cTBS), a electromagnetic coil is placed against the while an electromagnet painlessly delivers magnetic bursts that stimulate nerve cells in the target brain region
Study: NCT01873495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omacetaxine
Description: Omacetaxine 1.25 mg/m² sub-cutaneously twice daily for 5 consecutive days every 28 (± 8) days for 3 cycles.~Patients in continuous remission after 3 cycles of consolidation will receive maintenance omacetaxine 1.25 mg/m² twice daily for 3 days, every 28 days for up to 6 cycles
Study: NCT03873493

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax tablets taken orally once a day (QD). Initially, venetoclax was administered utilizing a 5-step dose ramp-up over 5 days. Subjects were hospitalized and closely monitored for 7 days. The venetoclax ramp-up was administered in a daily manner: 20 mg on Week 1 Day 1, 50 mg on Week 1 Day 2, 100 mg on Week 1 Day 3, 200 mg on Week 1 Day 4, and 400 mg on Week 1 Day 5 and thereafter, once daily, until the end-of-treatment. The dose of venetoclax may have been increased to 600 mg QD at Week 8 or thereafter.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Ibrutinib capsules taken orally once a day, 420 mg/day until the end-of-treatment.
Study: NCT03258333

Intervention type: PROCEDURE
Intervention: aortic valve replacement
Description: Standart AVR using stented stented bioprosthesis aortic valve reconstruction using autologus pericardium

Intervention type: PROCEDURE
Intervention: aortic valve replacement
Description: Standart AVR using stented stented bioprosthesis aortic valve reconstruction using autologus pericardium
Study: NCT03756350

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 1060nm diode laser
Description: Non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, four 1060nm diode laser applicators which are 60x60 mm in size. There is a belt included with the system to allow for the secure application of the applicators to the treatment area.
Study: NCT03157232

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rainbow DCI and R1-25 sensor
Description: Noninvasive Measurement of SpHb
Study: NCT05241509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cymbopogon citratus (lemongrass) oil gel
Description: Biochemical Efficacy of Cymbopogon Citratus Gel as Local Drug Delivery Agent in Reducing Matrix Metalloproteinase-8 Levels Intra-crevicularly in the Treatment of Stage II Periodontitis

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cymbopogon citratus (lemongrass) oil gel
Description: Biochemical Efficacy of Cymbopogon Citratus Gel as Local Drug Delivery Agent in Reducing Matrix Metalloproteinase-8 Levels Intra-crevicularly in the Treatment of Stage II Periodontitis
Study: NCT02206165

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Candesartan 8mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan 8mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan 8mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Candesartan 16mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan 16mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan 16mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine 5mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine 10mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 10mg
Description: Once a day, 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 10mg
Description: Once a day, 8 weeks
Study: NCT05370066

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CS6BP watches will be used in the study.
Description: CS6BP watches will be used with FDA approved Blood pressure monitors
Study: NCT03343951

Intervention type: OTHER
Intervention: Examination
Description: Patients will be examined twice the same day by an extended scope physiotherapist (ESP) and an orthopaedic surgeon (OS) in random order. They will independently and blinded to each other's opinion register~* diagnosis and treatment plan (including need for further diagnostic examinations - i.e. imaging)~* if the patient needs a new appointment at the shoulder clinic~* if they under usual conditions would discuss their results with the opposite health professional before deciding diagnosis and treatment plan.~After the individual examinations the ESP and OS discuss their results and come to an agreement (common decision) regarding the patient's diagnosis, treatment plan and need of a new appointment. Patients will be informed only of the common decision of the ESP and OS.
Study: NCT04162925

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cancer screening education for breast, colon and oral cancers
Description: Bedside education one-on-one by showing screening video and handouts at the end of educational session for breast, colon and oral cancer. Patient who are agreeable to oral cancer screen during hospitalization perform oral cancer screening
Study: NCT03268733

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folic Acid
Description: Tablet 5 mg
Study: NCT01256658

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: COA566
Description: COA566 tablets or dispersible tablets twice daily during 3 days; dosage according to body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: COA566
Description: COA566 tablets or dispersible tablets twice daily during 3 days; dosage according to body weight.
Study: NCT02614534

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MITOMYCIN-C 30 mg
Description: Proactive cytoreductive surgery: Tumoral cytoreductive surgery + apendicectomy + total omentectomy + round hepatic ligament + oophorectomy (postmenopausian women) plus HIPEC with Mytomicin C for 60 minutes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Proactive cytoreductive surgery
Description: Proactive cytoreductive surgery: Tumoral cytoreductive surgery + apendicectomy + total omentectomy + round hepatic ligament + oophorectomy (postmenopausian women)
Study: NCT02350179

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: This will be a prospective, randomized controlled trial that will be carried at Obstetrics and Gynecology Department, Ain Shams Maternity Hospital.~The study will include 100 pregnant women with singleton fetus 38 or more weeks gestation who will be divided in to two groups.~Study group will include 50 women and control group will include 50 women. Women assigned to the study group will receive 1 gr of TXA injection (Kapron, AMOUN Pharmaceutical co.) given slowly I.V over 10 minutes before the operation.~The control group will receive 30ml of 5% glucose. Both provider and patient will be double-blinded until the conclusion of the study.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Glucose
Description: The control group will receive 30ml of 5% glucose. Both provider and patient will be double-blinded until the conclusion of the study.
Study: NCT04815954

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Urinary catheter removal
Description: Removal of urinary catheter which was placed during kidney transplantation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Urinary catheter removal
Description: Removal of urinary catheter which was placed during kidney transplantation.
Study: NCT03298568

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: DAOsin
Description: DAOsin is a food supplement for special medical purpose for the treatment of food intolerance provoked by histamine intake.
Study: NCT01440777

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Go! to Sleep
Description: The online program provides various tools for the delivery of the intervention including:~* Daily articles~* Daily activities to help get the sleep you need~* Daily sleep improvement recommendations~* Audio recorded relaxation exercises~* Daily e-mails from your program coach~* Personal progress charts~* An online sleep log and daily sleep score
Study: NCT03726580

Intervention type: DRUG
Intervention: Sevoflurane
Description: Assess the effect of isoflurane, sevoflurane, propofol and regional anesthesia on the olfactory threshold, olfactory identification and endocrine regulation of associative memory in the postoperative period in old age group.
Study: NCT01551186

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG
Description: 1 capsule containing 10 billion cells of Lactobacillus rhamnosus GG on a twice-daily basis
Study: NCT01571765

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MNCH programming in health district
Description: training at health district level in management, data collection. Training at health centres in obstetrics and pediatrics and training in community of CHWs and bednet distribution
Study: NCT00752531

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Automated Telemanagement (HAT)
Description: The HAT was designed as an Internet-based telemedicine system that (1) provides ongoing education to patients about their chronic disease, (2) helps patients follow their self-care plans, and (3) helps health care practitioners monitor their patients' self-management processes according to current clinical guidelines. During each telecommunication session, patients perform self-testing and receive structured disease-specific education, patient-tailored counseling, and advice on how to follow their individual self-care plans based on the current results of self-testing.
Study: NCT02877472

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: porous tantalum rod
Description: Patients with avascular necrosis of the femoral head after femoral head fracture surgery receive treatment of core decompression and porous tantalum rod implantation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: core decompression
Description: Patients with avascular necrosis of the femoral head after femoral head fracture surgery will undergo core decompression.